Toward a General Approach for RNA-Templated
Hierarchical Assembly of Split-Proteins by Furman, Jennifer L. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Cliff Stains Publications Published Research - Department of Chemistry 
2010 
Toward a General Approach for RNA-Templated Hierarchical 
Assembly of Split-Proteins 
Jennifer L. Furman 
University of Arizona 
Ahmed H. Badran 
University of Arizona 
Oluyomi Ajulo 
University of Arizona 
Jason R. Porter 
University of Arizona 
Cliff I. Stains 
University of Nebraska-Lincoln, cstains2@unl.edu 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/chemistrystains 
 Part of the Chemistry Commons 
Furman, Jennifer L.; Badran, Ahmed H.; Ajulo, Oluyomi; Porter, Jason R.; Stains, Cliff I.; Segal, David J.; and 
Ghosh, Indraneel, "Toward a General Approach for RNA-Templated Hierarchical Assembly of Split-
Proteins" (2010). Cliff Stains Publications. 5. 
https://digitalcommons.unl.edu/chemistrystains/5 
This Article is brought to you for free and open access by the Published Research - Department of Chemistry at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Cliff Stains Publications by 
an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Jennifer L. Furman, Ahmed H. Badran, Oluyomi Ajulo, Jason R. Porter, Cliff I. Stains, David J. Segal, and 
Indraneel Ghosh 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
chemistrystains/5 
Introduction
The ability to conditionally elicit a response in the presence 
of a user-defined macromolecular target has great potential in 
biosensor design, targeted therapeutics, and a variety of appli-
cations in synthetic biology. With our enhanced understand-
ing of the human genome, both DNA and RNA have become 
increasingly important biological targets related to diverse hu-
man disease.1 General methods for nucleic acid targeting now 
include several hybridization based approaches such as RNA 
interference (RNAi), triplex-forming oligonucleotides (TFOs), 
peptide nucleic acids (PNAs), as well as the elegantly designed 
polyamides.2 Nucleic acid detection most commonly relies on 
fluorescently labeled oligonucleotides, as in the case of fluo-
rescence in situ hybridization (FISH).3 However, the consti-
tutive fluorescent signal associated with this class of probes 
necessitates washing steps and results in reduced sensitiv-
ity, which potentially limits the utility of this technique for in 
vivo imaging.4 To address these concerns, recent efforts have 
been directed toward generating “turn-on” fluorescent or elec-
trochemical sensors, which couple conditional signal output 
to target binding.5 In a complementary approach, there has 
been recent interest in DNA- and RNA-templated reactions, 
wherein probe localization on a single-stranded nucleic acid 
target enables the specific chemical transformation of attached 
moieties.6 Examples of nucleic acid-templated chemical reac-
tions include FRET- and quencher-based autoligation probes, 
metallosalen−DNA conjugates and deoxyribozymes for DNA 
hydrolysis, and catalytically released cytotoxic drugs.7 Addi-
tionally, there is great interest in the design of DNA-directed 
gain of function proteins, which cannot only serve as sensors 
and genome modifying agents, but also have potential as spe-
cific therapeutics. Many groups have described protein-based 
approaches for the conditional reassembly of fragmented pro-
teins on double-stranded DNA (dsDNA) mainly utilizing the 
Cys2His2 class of zinc fingers (ZFs) as targeting domains.8, 9 
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Abstract
The ability to conditionally turn on a signal or induce a function in the presence of a user-defined RNA target has potential ap-
plications in medicine and synthetic biology. Although sequence-specific pumilio repeat proteins can target a limited set of ss-
RNA sequences, there are no general methods for targeting ssRNA with designed proteins. As a first step toward RNA rec-
ognition, we utilized the RNA binding domain of argonaute, implicated in RNA interference, for specifically targeting generic 
2-nucleotide, 3′ overhangs of any dsRNA. We tested the reassembly of a split-luciferase enzyme guided by argonaute-medi-
ated recognition of newly generated nucleotide overhangs when ssRNA is targeted by a designed complementary guide se-
quence. This approach was successful when argonaute was utilized in conjunction with a pumilio repeat and expanded the 
scope of potential ssRNA targets. However, targeting any desired ssRNA remained elusive as two argonaute domains pro-
vided minimal reassembled split-luciferase. We next designed and tested a second hierarchical assembly, wherein ssDNA 
guides are appended to DNA hairpins that serve as a scaffold for high affinity zinc fingers attached to split-luciferase. In the 
presence of a ssRNA target containing adjacent sequences complementary to the guides, the hairpins are brought into prox-
imity, allowing for zinc finger binding and concomitant reassembly of the fragmented luciferase. The scope of this new ap-
proach was validated by specifically targeting RNA encoding VEGF, hDM2, and HER2. These approaches provide potentially 
general design paradigms for the conditional reassembly of fragmented proteins in the presence of any desired ssRNA target.
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However, the design of general approaches for targeting sin-
gle-stranded RNA (ssRNA) that elicit the conditional reassem-
bly of functional proteins remains a challenging enterprise. 
As recently discussed by Varshavsky, the possibility of selec-
tively targeting genetic modifications in malignant cells may 
be achieved through the implementation of DNA targeted 
split-protein reassembly based strategies.10 Herein, we detail 
our progress toward the long-term goal of RNA dependent 
conditional split-protein assembly for potentially modulating 
cell viability by utilizing several iterative designs that combine 
split-protein methods with nucleic acid targeting and nucleic 
acid hybridization approaches.
The split-protein reassembly methodology or protein com-
plementation assay (PCA) has been most commonly ap-
plied toward the elucidation of protein−protein interactions, 
wherein conditional protein reassembly is facilitated by the 
direct interaction of appended domains.11 This methodology, 
starting with ubiquitin, has been expanded to several mono-
meric proteins such as the green fluorescent protein (GFP), 
β-lactamase, luciferases, and tobacco etch virus (TEV) prote-
ase.12 Building on these approaches, we have previously re-
ported a ternary DNA-templated split-protein reassembly 
system, in which conditional signal output is coupled to the 
presence of a unique DNA target. In this approach the se-
quence-specific binding of ZF domains to targeted DNA in-
duces reassembly of the appended split-signaling protein, 
which comprises GFP and variants, β-lactamase, or firefly lu-
ciferase.8, 13 This strategy has since been adapted for RNA-tem-
plated assembly by utilizing sequence-specific RNA binding 
proteins called pumilio domains (Figure 1A).13b, 14 However, 
there are presently no general approaches for sequence-specif-
ically assembling genetically encoded proteins on any user-de-
fined ssRNA target. Interestingly, in a related DNA-directed 
approach, split-GFP has been conjugated to single-stranded 
DNA (ssDNA) oligonucleotides, either chemically or through 
a biotin/streptavidin linkage, allowing for hybridization-de-
pendent GFP reassembly.15 In another elegant DNA-directed 
approach, a split-peroxidase DNAzyme attached to ssDNA 
domains was designed, which detected 1 μM complementary 
DNA.16 Alternate conditional assembly approaches involve 
the design of sensitive multicomponent nucleic acid enzymes 
(MNAzymes) or high specificity binary DNA probes.17 Build-
ing upon these studies, we sought to develop a potentially 
general method that allows for recognizing any ssRNA target, 
leading to the conditional reassembly of a fragmented protein.
Toward this long-term goal, we herein describe the itera-
tive design of a series of RNA-templated assemblies utilizing 
split-luciferase, which provides a convenient sensor and sur-
rogate for split-proteins in general.13b In our previous DNA-
templated reassembly systems, we achieved target binding 
through a direct protein−target interaction, thereby inducing 
split-protein reassembly. To create a more general approach 
for targeting an expanded set of ssRNA sequences, we initially 
investigated the use of the PAZ domain of argonaute 2.18 Ar-
gonaute (Ago), which is central to the dicer complex produced 
during RNAi,2 has been reported to bind to the 2-nucleotide 
(nt), 3′ overhangs of short double-stranded RNA (dsRNA).18 
Thus, by providing complementary guide oligonucleotides 
Figure 1. Cartoon representations of pumilio, argonaute, and zinc finger domains attached to split-luciferase. The presence of target ssRNA results in lucif-
erase reassembly and a luminescent signal. (A) Pumilio (Pum) RNA binding proteins confer specificity for a particular RNA sequence. (B) Argonaute (Ago)-
mediated detection strategies involve recognition of a 3′ 2-nucleotide overhang generated by the binding of short guide sequences of RNA to a complemen-
tary target. (C) Zinc fingers (ZF) bind to dsDNA hairpins localized to adjacent sites on an RNA target via hybridization of attached guide sequences. CFluc, 
C-terminal fragment of luciferase; NFluc, N-terminal fragment of luciferase.
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similar to those used in RNAi, short regions of dsRNA are 
generated in the template, creating a platform for Ago bind-
ing and split-luciferase reassembly. This quaternary assem-
bly strategy, which utilizes a pumilio domain in conjunction 
with Ago, provides a basis for potentially recognizing any 
given RNA target (Figure 1B). In an alternative design, we en-
visioned that we could attach designed dsDNA hairpins to ss-
DNA guides complementary to the template, thus, providing 
a binding site for high affinity (Kd ~ low pM), sequence-spe-
cific ZFs appended to split-luciferase (Figure 1C). These “hair-
pin-guides” would potentially allow ZF-mediated split-lucif-
erase reassembly only in the presence of the ssRNA or ssDNA 
template. Herein, we demonstrate that these approaches po-
tentially provide a general paradigm for selectively recogniz-
ing a variety of user-defined ssRNA targets known to be over-
expressed in human disease.
Results and Discussion
RNA-Templated Assembly Using Argonaute. In our quest 
to expand upon our existing pumilio-based split-firefly lucifer-
ase system for RNA-templated assembly (Figure 2A),13b we in-
corporated an RNA binding protein, the PAZ domain of Homo 
sapiens Ago2. Given that this domain from Ago1 (96% domain 
similarity) binds with high affinity (Kd = 2.18 nM) to the 2-nt, 3′ 
overhangs of short dsRNA,18a we postulated that we would be 
able to direct our split-proteins toward any RNA template by 
providing short, complementary guide oligonucleotides simi-
lar to those used in RNAi. We chose the RNA sequence bound 
by the pumilio proteins as our initial nucleic acid target to al-
low for the direct comparison between designs. This RNA se-
quence, 5′-CAUGGUGUAUAUAGUCUUUUGAUAUAGC-
GGC, comprises two 8-nt pumilio binding sites (underlined), 
separated by 5-nt and flanked on either side by 5-nt. We ini-
tially designed a 16-nt guide (5′ guide), which consisted of 14-nt 
complementary to the 5′ end of the RNA template and a 3′UU 
sequence serving to generate the 2-nt, 3′ overhang required for 
Ago binding (Supporting Information Table S1). A diuridine 
overhang was selected since this sequence is efficiently recog-
nized by Ago as determined by siRNA gene knockdown exper-
iments.19 Thus, to test the utility of Ago in this hierarchical as-
sembly strategy, we attached Ago (residues 227−371) through 
an 18 amino acid linker to the carboxy terminus of the C-ter-
minal luciferase fragment (residues 398−550), generating CLu-
ciferase−Ago. We then produced CLuciferase−Ago and Pum2−
NLuciferase in a cell-free translation system, which has been 
previously used to rapidly express proteins for split-protein 
approaches.13b We initiated reassembly by hybridizing the 5′ 
guide to the RNA template. Following incubation of the split-
luciferase constructs with the prehybridized guide-template 
complex at 10 nM, a significant signal over background of 18-
fold was observed (Figure 2B). To our knowledge, this is the 
first example of Ago being employed in a hierarchal assembly 
approach, providing a general building block in nucleic acid-
templated reassembly of split-proteins.
In a complementary set of experiments, we generated Ago−
NLuciferase by fusing the Ago domain (residues 227−371) 
through a 17 amino acid linker to the amino terminus of the 
N-terminal fragment of luciferase (residues 2−416) and de-
signed an appropriate guide sequence (3′ guide) for target-
ing the 3′ end of the RNA target, again incorporating a 3′UU 
overhang for Ago binding (Supporting Information Table S1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It has been observed in the crystal structure of H. sapiens 
Ago1 (PDB 1SI2) that, in addition to making significant con-
tacts along the RNA backbone of the strand containing the 3′ 
overhang, Ago also interacts with the 5′ terminal residue on 
the complementary strand.18a In the orientation described for 
the RNA target and 3′ guide, a 5′ terminal residue is not gen-
erated, which may reduce the affinity of Ago for the nucleic 
acid complex in this configuration. Despite this potential dis-
advantage, CLuciferase−Pum1 and Ago−NLuciferase were 
still successfully used to bind 10 nM target, resulting in lucif-
erase reassembly with a 4.5-fold signal over background (Fig-
ure 2C). Finally, to provide a general solution to ssRNA-tem-
plated protein assembly exclusively predicated on recognition 
by Ago domains, we hybridized both guide sequences to the 
target. However, upon incubation of the ternary guide−tem-
plate complex at 10 nM with CLuciferase−Ago and Ago−NLu-
Figure 2. ssRNA-templated reassembly of luciferase using pumilio (Pum) 
and argonaute (Ago) domains. (A) CLuciferase−Pum1 and Pum2−NLu-
ciferase biosensors were reassembled in the presence of 10 nM cognate 
RNA. (B) CLuciferase−Ago and Pum2−NLuciferase were reassembled in 
the presence of 10 nM RNA annealed to the 5′ guide. (C) CLuciferase−
Pum1 and Ago−NLuciferase were reassembled in the presence of 10 nM 
RNA annealed to the 3′ guide. (D) The RNA target was annealed to the 5′ 
guide and 3′ guide to generate proximate Ago binding sites. CLuciferase−
Ago and Ago−NLuciferase biosensors were reassembled in the presence 
of the annealed target (10 nM). In all cases, the CLuciferase (CFluc) fu-
sion proteins are shown in pink, the NLuciferase (NFluc) fusion proteins are 
shown in blue, the RNA template is red, and the guides are shown in tan. 
RLU, relative luminescent units.
19. Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tus-
chl, T. EMBO J. 2001, 20, 6877–6888
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ciferase, less than a 2-fold signal increase was observed (Fig-
ure 2D). We additionally assessed these constructs utilizing a 
longer 5′ guide sequence, as well as larger Ago domains (res-
idues 207−391), with no improvement in signal (Supporting 
Information Figure S1). The low signal over background ap-
peared to be a function of a reduced luminescent signal in the 
presence of the ternary nucleic acid template, rather than an 
increase in background, implying a lack of Ago localization to 
the intended guides. This may be attributable to the affinity of 
Ago for a potentially noncognate target as well as the expec-
tation that utilizing both guide sequences in tandem results 
in a statistical distribution of Ago-luciferase halves bound to 
the RNA target, permitting only 50% split-luciferase comple-
mentation (Supporting Information Figure S2). Thus, these ex-
periments suggest that Ago may be employed successfully in 
conjunction with other available sequence-specific RNA bind-
ing domains, and its use allows one to access a larger detect-
able sequence space than pumilio domains alone.
dsDNA-Templated Assembly of High Affinity Zinc Fin-
gers. As a second design, we sought to create a more general, 
sequence-specific, ssRNA-templated assembly strategy with-
out the need for programming nucleic acid binding proteins 
for each new ssRNA template. Learning from the Ago-guide 
strategy, which combines targeted protein and hybridization 
strategies, we envisioned that attachment of high affinity, se-
quence-specific ZFs to our split-proteins could serve as a mo-
tif for displaying any user-defined ssDNA guide directly ap-
pended to a ZF hairpin (HP) binding site, thus, providing a 
HP-guide. These HP-guides would potentially allow ZF-medi-
ated split-luciferase reassembly only in the presence of a tar-
geted ssRNA or ssDNA sequence. For this pentameric com-
plex to be productively assembled, we reasoned that the 
interaction between the ZFs and their dsDNA binding sites 
should be very high affinity to ensure that signal generation 
is predicated on the interaction between the guides and their 
complementary target and is not limited by the interaction of 
the ZFs with their respective binding sites.
Toward this goal, we investigated the use of two well-char-
acterized and high affinity six-finger ZFs, E2C (Kd ~ 500 pM) 
and Aart (Kd ~ 7.5 pM), and initially evaluated these domains 
for dsDNA-templated assembly (Figure 3A).20 Thus, we uti-
lized a construct in which E2C (residues 7−180) was attached 
to the carboxy terminus of the C-terminal luciferase fragment 
(residues 398−550), creating CLuciferase−E2C, while Aart (res-
idues 17−190) was fused to the amino terminus of the N-ter-
minal luciferase fragment (residues 2−416), generating Aart−
NLuciferase. We initially tested this system for preferential 
luciferase reassembly in the presence of an optimized cognate 
dsDNA template, E2C-1-Aart (5′- GCGTAGGGGCCGGAGC-
CGCAGTGGATGTAGGGAAAAGCCCGGTACCG), consist-
ing of E2C and Aart ZF binding sites (underlined) separated 
by 1-nt and flanked on either side by 5-nt. Using 300 pM tar-
get, a 78-fold signal over background was observed (Figure 
3B). Importantly, signal generated from the ternary complex 
in the presence of a 100-fold mass excess of genomic herring 
sperm DNA was unperturbed (Figure 3B). Additionally, min-
imal background signal was generated in the presence of her-
ring sperm DNA alone, suggesting low nonspecific binding 
for these 6-finger ZFs.
We next performed a series of experiments to character-
ize the system. dsDNA titrations with decreasing amounts 
of E2C-1-Aart revealed a detection limit of 2 pM (200 amol) 
that was detectable over the average background signal plus 
three standard deviations (99% confidence level), thus, pro-
viding our most sensitive dsDNA-directed assembly system 
 
 
 
 
 
20. (a) Beerli, R. R., Segal, D. J., Dreier, B., and Barbas, C. F., III. Proc. 
Natl. Acad. Sci. U.S.A. 1998, 95, 14628–14633; (b) Dreier, B., Beerli, 
R. R., Segal, D. J., Flippin, J. D., and Barbas, C. F., III. J. Biol. Chem. 
2001, 276, 29466–29478; (c) Segal, D. J., Crotty, J. W., Bhakta, M. S., 
Barbas, C. F., III., and Horton, N. C. J. Mol. Biol. 2006, 363, 405–421
Figure 3. Evaluation of 6-finger zinc 
fingers E2C and Aart for split-lucifer-
ase reassembly. (A) CLuciferase−E2C 
(pink) and Aart−NLuciferase (blue) 
bind to a total of 36 base pairs in tar-
get DNA (tan), as monitored by a lumi-
nescent signal. (B) The CLuciferase−
E2C and Aart−NLuciferase biosensors 
were reassembled in the presence of 
300 pM (920 pg) E2C-1-Aart DNA, 300 
pM E2C-1-Aart DNA + 92 ng (100-fold 
mass excess) herring sperm DNA (HS-
DNA), 92 ng HS-DNA only, or No DNA. 
(C) The CLuciferase−E2C and Aart−
NLuciferase biosensors were reassem-
bled in the presence of 100, 50, 25, 10, 
5, or 2 pM E2C-1-Aart DNA, followed 
by luminescence readings. The raw 
data is presented in Supporting Infor-
mation Table S3. (D) CLuciferase−E2C 
and Aart−NLuciferase were reassem-
bled in the presence of 300 pM E2C-
1-Aart DNA, and 300, 100, 50, 10, 5, 
1, 0.5, or 0.1 nM Aart competitor hair-
pin was used to knock down lucifer-
ase signal. RLU, relative luminescent 
units. CFluc, C-terminal fragment of lu-
ciferase; NFluc, N-terminal fragment of 
luciferase.
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to date (Figure 3C, Supporting Information Table S3). Finally, 
we demonstrated the ability of these 6-finger ZFs to bind de-
signed dsDNA HPs, as required for the envisioned RNA-
templated pentameric assembly strategy. Translations of the 
split-proteins, CLuciferase−E2C and Aart−NLuciferase, were 
initiated in the presence of the target oligonucleotide E2C-1-
Aart with or without an Aart competitor HP (Supporting Infor-
mation Table S1). A competitor HP concentration-dependent 
decrease in luminescence was observed (IC50 = 7 nM), con-
firming that HPs can be designed as ZF binding sites (Figure 
3D), thus, providing a platform for the adaptation of this ter-
nary sensor for pentameric RNA-directed assembly.
Investigating Covalently Tethered Luciferase Variants. 
To ensure that we had designed an optimal luciferase reas-
sembly system with sufficient flexibility to permit refolding, 
we systematically evaluated a series of split-luciferase con-
structs in which the C-terminal fragment of luciferase (res-
idues 398−550) is covalently tethered to the amino termi-
nus of the N-terminal fragment of luciferase (residues 2−416) 
through a linker of variable length (Figure 4A). Accordingly, 
the efficiency of luciferase reassembly for this series of CLu-
ciferase-linker-NLuciferase constructs should be predicated 
on the length of the linker adjoining the inverted halves and 
will determine approximate linker constraints for future con-
structs. Considering that the linear distance between the na-
tive amino and carboxy termini of luciferase is 39 Å based 
on a high-resolution crystal structure (PDB 1LCI), the linker 
lengths selected were 8 amino acids (AA), 14 AA, 18 AA, 23 
AA, and 28 AA (Supporting Information Figure S3), which, re-
spectively, correspond to approximate linear distances (in ex-
tended configurations of 3.5 Å per AA) of 25, 46, 60, 77, and 95 
Å.21 Upon translating each construct in a cell-free system, we 
observed a maximum luminescent signal at 23 AA, suggest-
ing that 77 Å is sufficient to minimize conformational strain on 
the system associated with shorter linkers (Figure 4B). A trans-
lation performed in the presence of 35S-methionine served to 
ensure that differences in luminescence were not a function of 
variable protein expression (Supporting Information Figure 
S3). These results imply that the total linker length between 
each luciferase half and its conjugated domain must at mini-
mum be greater than 23 AA. Our current linkers of 18 and 17 
AA for CLuciferase−E2C and Aart−NLuciferase, when consid-
ered collectively (35 AA), are in excess of this minimum con-
straint and as such should provide sufficient length to allow 
for efficient luciferase reassembly.
ssRNA and ssDNA-Templated Assembly of Split-Lu-
ciferase. As noted above, the designed 6-finger ZFs E2C and 
Aart potentially confer high sensitivity for binding to a pre-
defined, cognate dsDNA target. However, despite the avail-
ability of ZF motifs that bind ssRNA, programmability of 
these domains for detection of a user-defined sequence is cur-
rently precluded by the lack of a recognition code.22 We there-
fore sought to harness the sensitivity and specificity of the 
ZF−dsDNA interaction by utilizing a bridging domain to rec-
ognize single-stranded nucleic acid polymers, with an empha-
sis on ssRNA-templated assembly. As such, we attached ZF 
HP binding sites to guide sequences of ssDNA, which serve 
to target adjacent sequences in a user-defined RNA template. 
Thus, assembly is initiated by the guide sequences binding to 
proximal sites in their defined target, thereby localizing the ZF 
binding sites and allowing for binding of the split-luciferase 
conjugated ZFs (Figure 5A).
We initially tested this pentameric reassembly strategy by 
targeting the RNA sequence recognized by the pumilio proteins 
in order to compare results between the different designs. Given 
the short length of the template (31-nt), we selected guides with 
lengths of 14- and 13-nt, which have complementary sites in the 
template separated by 4-nt to prevent any steric conflicts (Fig-
ure 5B). The designed HP-guide (E2C-5′ guide), which serves 
as a binding site for E2C and contains a sequence comple-
mentary to the 5′ end of the RNA target, is 5′-GAGGGGCCG-
GAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCT-
CAAAACTATATACACCATG. The portions forming the HP 
dsDNA binding site for E2C (underlined) and connected by a 
TCCT loop are adjoined to the sequence complementary to the 
target (bold) by a poly(A)4 linker. The HP-guide (3′ guide-Aart) 
complementary to the 3′ end of the RNA target (bold) and con-
taining a HP binding site for Aart (underlined) is 5′-GCCGC-
TATATCAAAAAACTCCGGGCTTTTCCCTACATGCTCCTG-
CATGTAGGGAAAAGCCCGGAG. All subsequent HP-guides 
are derived from these configurations, only varying in the por-
tion complementary to the chosen target (Supporting Informa-
tion Table S1).
We tested the utility of our pentameric approach in a cell-
free translation system to generate our designed, ZF-modified, 
split-luciferase constructs. Addition of 1 nM ssRNA template 
hybridized to complementary HP-guides resulted in lucifer-
ase reassembly and a signal of 4.5-fold as compared to back-
ground (Figure 5C). We additionally demonstrated that the 
corresponding ssDNA target (1 nM) may also be used to tem-
plate reassembly with an identical signal over background of 
4.5-fold. To directly interrogate sequence selectivity, a single 
G to T mutation was introduced in the ssDNA, which reduced 
signal to background levels. Therefore, initial tests indicated 
that we had successfully developed a pentameric design that 
allows for the reassembly of functional proteins on specific 
single-stranded nucleic acid templates.
VEGF RNA-Templated Assembly of Split-Luciferase. To 
further probe the generality of our ssRNA-templated assembly 
approach, we selected a physiologically relevant RNA target 
that comprises nucleotides 109−403 of the vascular endothelial 
Figure 4. Evaluation of linker length in a covalently tethered luciferase con-
struct. (A) A CLuciferase-linker-NLuciferase construct, comprising residues 
398−550 of luciferase (pink) followed by a glycine−serine linker (red) and 
residues 2−416 of luciferase (blue), was generated to assess the effect of 
linker length on luciferase reassembly. The distance between the original 
N- and C-termini of luciferase is ~39 Å, and linkers were designed to vary 
from ~ 25 to 95 Å. AA, amino acids. (B) The CLuciferase-linker-NLuciferase 
constructs were each translated individually in a cell-free system, followed 
by luminescence readings to determine reassembly efficiency. ALU, arbi-
trary luminescent units. CFluc, C-terminal fragment of luciferase; NFluc, N-
terminal fragment of luciferase.
21. Conti, E., Franks, N. P., and Brick, P. Structure 1996, 4, 287–298 22. Hall, T. M. Curr. Opin. Struct. Biol. 2005, 15, 367–373
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growth factor (VEGF), which is overexpressed in certain can-
cers.23 Our previous ssRNA target was only 31-nt in length, 
and we were, therefore, limited in the choice of guide length 
and binding location. The VEGF transcript generated by in vi-
tro transcription was 295-nt in length, and consequently pre-
sented a significant expansion of potential guide binding sites. 
To reduce this collection to a manageable size from which suit-
able adjacent binding sites could be selected, we initially con-
sidered guide length and separation. Keeping in mind that 
sequence-specificity and binding affinity of probe−target in-
teractions are typically inversely proportional,24 we chose to 
use tandem guides of 19-nt, which are typically employed in 
designing siRNAs for use in RNAi.19 A separation of 2-nt was 
selected in an attempt to maximize the effective concentration 
of our localized luciferase halves, while minimizing any steric 
conflicts. Because probe accessibility can vary greatly within 
a given target due to the complex nature of RNA secondary 
structure,25 the final selections for targeting the 295-nt VEGF 
transcript were made based on the following considerations 
generally addressed in the design of any complementary oli-
gonucleotide: (1) maximization of thermodynamic stability 
between guide and target; (2) minimization of inappropriate 
secondary structures, such as hairpins, loops, cruciforms, tri-
plexes, or quadruplexes in the guide; and (3) minimization of 
complementarity to other nontarget sites.26
The above constraints led us to identify VEGF positions 
60−78 and 81−99 as appropriate target regions. The guide por-
tions of the existing HP-guides that were used to display re-
assembled luciferase on the previous ssRNA template were 
modified to incorporate the newly designed ssDNA oligonu-
cleotides complementary to the VEGF transcript (Support-
ing Information Table S1). Upon translating CLuciferase−E2C 
and Aart−NLuciferase in our cell-free system, we added our 
HP-guides annealed to 1 nM in vitro transcribed VEGF tar-
get and observed a 19-fold signal increase over the presence 
of HP-guides alone (Figure 6A). To further test the generality 
of our guide design strategy, we generated a second set of HP-
guides for targeting VEGF at positions 216−234 and 237−255 
 
 
 
 
 
 
 
 
 
 
(Supporting Information Table S1). Using these new guides, 
we similarly achieved signal over background when assayed 
under identical conditions as the 60−78 and 81−99 set (Sup-
porting Information Figure S4). We next performed a kinetic 
evaluation of luminescent signal as a function of incubation 
time with the ternary nucleic acid complex. Interestingly, sig-
nal over background was achieved after only 5 min of incu-
bation of the biosensors with the ternary target, providing an 
extremely rapid assembly method (Figure 6B). From 5 to 30 
min, the rate of signal generation increased quickly, followed 
by only modest gains thereafter. Therefore, all subsequent lu-
minescence readings were collected after a 30 min incubation, 
where ~10 pM (1 fmol) VEGF RNA was detectable over the 
average signal plus three standard deviations (99% confidence 
level) of the HP-guides alone (Figure 6C).
Next, we attempted to optimize our RNA-templated as-
sembly platform by altering the length of the complementary 
guide sequences in the HP-guides (Supporting Information 
Table S1). We tested lengths as short as 15-nt for each guide 
(30-nt total length of complementarity) and as long as 25-nt 
(50-nt total length of complementarity) (Figure 6D). We iden-
tified the original 19-nt guides (38-nt total length of comple-
mentarity) as providing the optimal signal over background 
(Figure 6E). This may be due to a compromise between an im-
proved binding affinity associated with longer guides and a 
lower propensity for forming undesired secondary structures 
in shorter guides. Finally, we tested the selectivity of the sys-
tem by detecting the annealed VEGF RNA target in the pres-
ence of a 2000-fold mass excess of Saccharomyces cerevisiae (bak-
er’s yeast) RNA. Yeast was selected since this organism lacks 
a complementary binding site (Supporting Information Table 
S4). The VEGF RNA was selectively detected at 500 pM (5.0 
ng) in the presence of 10 μg of yeast RNA, generating a signal 
(25-fold) as high as in the presence of target alone (Figure 6F, 
Supporting Information Figure S5). Additionally, the absence 
of luciferase activity observed in the presence of nonspecific 
yeast RNA is indicative of the high selectivity of the system af-
forded by the designed guide sequences.
Detection of hDM2 and HER2 ssRNA Targets. To further 
establish the generality of our ZF-mediated, ssRNA-templated 
assembly methodology, we selected two additional ssRNA 
templates: the human homologue of murine double minute 
2 (hDM2) and the human epidermal growth factor receptor 2 
(HER2). HP-guides were designed for binding two adjacent 
19-nt sequences present in the 549-nt hDM2 and 201-nt HER2 
in vitro transcribed targets. Under the conditions optimized for 
VEGF RNA-mediated assembly, the presence of each of the 
newly introduced targets (1 nM) yielded luminescent signal 
Figure 5. Nucleic acid-templated split-luciferase reassembly. (A) The designed hairpin-guides (tan) target a complementary single-stranded nucleic acid 
(red), providing proximate binding sites for CLuciferase−E2C (pink) and Aart−NLuciferase (blue) and resulting in generation of a luminescent signal. (B) Tar-
get oligonucleotide sequences detected by nucleic acid-templated reassembly. Guides were designed to be complementary to the underlined portions. The 
single base mutation in the ssDNA target is highlighted in red. (C) Designed hairpin-guides were annealed to 1 nM ssRNA and ssDNA. CLuciferase−E2C 
and Aart−NLuciferase were incubated with the annealed targets, followed by luminescence readings. RLU, relative luminescent units. CFluc, C-terminal 
fragment of luciferase; NFluc, N-terminal fragment of luciferase.
23. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Nature 1992, 359, 
845–848
24. Demidov, V. V. and Frank-Kamenetskii, M. D. Trends Biochem. Sci. 
2004, 29, 62–71
25. (a) Fuchs, B. M., Wallner, G., Beisker, W., Schwippl, I., Ludwig, W., and 
Amann, R. Appl. Environ. Microbiol. 1998, 64, 4973–4982; (b) Sny-
der, T. M., Tse, B. N., and Liu, D. R. J. Am. Chem. Soc. 2008, 130, 
1392–1401
26. (a) Vickers, T. A., Wyatt, J. R., and Freier, S. M. Nucleic Acids Res. 
2000, 28, 1340–1347; (b) Martin, S. E. and Caplen, N. J. Annu. Rev. 
Genomics Hum. Genet. 2007, 8, 81–108
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over the presence of the respective HP-guides alone (Figure 
7A,B). These results suggest that, with no other modifications 
to the reaction conditions, a user may employ any of a number 
of targets for templated assembly in a straightforward manner 
by simply selecting an appropriate guide sequence.
With successful reassembly in the presence of each RNA 
target, we observed slight divergence in the associated sen-
sitivity of binding. Under identical conditions, a 7-fold sig-
nal over the presence of HP-guides alone was achieved for the 
hDM2 target (Figure 7A), and a 5-fold signal was associated 
with HER2 detection (Figure 7B), as compared to a 19-fold sig-
nal for the VEGF template (Figure 6A). Interestingly, these sig-
nals do not correlate with target length or predicted melting 
temperatures of the guide−target duplex. It is possible that 
these differences in signal over background that are within 
1 order of magnitude may be a function of local secondary 
structure in the targeted region. In future studies, systematic 
variation of the targeted region within a given transcript could 
provide insight into signal deviations and may ultimately pro-
vide improved detection limits.
Finally, we tested the orthogonal nature of our RNA-di-
rected assembly strategy. Thus, we attempted annealing of 
each in vitro transcribed target (VEGF, hDM2, or HER2) with 
each set of HP-guides, both complementary and noncomple-
mentary to the target. Upon incubation with our translated 
split-proteins, we observed signal only in the cases where the 
Figure 6. VEGF ssRNA-templated reassembly of split-luciferase. (A) CLuciferase−E2C and Aart−NLuciferase biosensors were reassembled in the pres-
ence of a 295-nucleotide (nt) VEGF transcript (1 nM) annealed to designed hairpin-guides with guide lengths of 19-nt. (B) CLuciferase−E2C and Aart−NLu-
ciferase were incubated for 5, 10, 20, 30, 45, or 60 min with the VEGF target (1 nM) annealed to hairpin-guides with guide lengths of 19-nt, followed by lu-
minescence readings. (C) CLuciferase−E2C and Aart−NLuciferase were reassembled in the presence of decreasing concentrations, 500, 250, 125, 62.5, 10 
pM, of the VEGF target annealed to hairpin-guides with guide lengths of 19-nt. Upon subtraction of the luminescence contributed by the corresponding No 
target samples, a linear response to change in RNA concentration is observed (inset). (D) The length of the complementary guides (red) was varied (15, 17, 
19, 21, 23, or 25-nt) to identify the optimal length. (E) Pairs of the hairpin-guides described in panel D were annealed to the VEGF target (1 nM), and incu-
bated with CLuciferase−E2C and Aart−NLuciferase, followed by luminescence readings. The length of guides is presented as the combined length of com-
plementarity of a pair of guides. (F) The annealed VEGF target (500 pM = 5.0 ng) was added to ~ 2000-fold mass excess (10 μg) of yeast RNA and was in-
cubated in the presence of CLuciferase−E2C and Aart−NLuciferase, followed by luminescence readings. ALU, arbitrary luminescent units. CFluc, C-terminal 
fragment of luciferase; NFluc, N-terminal fragment of luciferase.
Figure 7. Generality of ssRNA detection. Hairpin-guides were designed to target two additional physiologically relevant transcribed RNAs: (A) human homo-
logue of murine double minute 2 (hDM2) and (B) human epidermal growth factor receptor 2 (HER2). The sequences to which complementary guides were 
designed are indicated with targeted positions shown in parentheses. The designed hairpin-guides were annealed to their intended targets, followed by in-
cubation of 1 nM annealed target with the CLuciferase−E2C and Aart−NLuciferase biosensors. (C) The hDM2, HER2, and VEGF hairpin-guides were each 
annealed in the presence of 1 nM hDM2, HER2, and VEGF RNA targets, followed by incubation with CLuciferase−E2C and Aart−NLuciferase. ALU, arbi-
trary luminescent units.
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target was annealed to its complementary set of HP-guides, 
thus, confirming the high specificity associated with our de-
signed system (Figure 7C).
Conclusion
Conditional enzyme activation under defined cellular con-
ditions has utility in synthetic biology and therapeutic appli-
cations. Herein, we have described a series of single-stranded, 
nucleic acid-templated strategies for conditionally reconsti-
tuting split-proteins. Specifically, we have developed a po-
tentially general and robust methodology that utilizes nucleic 
acid binding domains, including pumilio, argonaute, and zinc 
fingers, for the templated reassembly of fragmented proteins 
on user-defined ssRNA and ssDNA targets. Utilizing our pre-
viously established pumilio-based split-luciferase reassembly 
technique as a starting point, we pursued the design of a mod-
ular and programmable means for sequence-specifically de-
tecting any single-stranded nucleic acid of interest.13b We ini-
tially utilized the RNA binding domain of argonaute, which 
binds to the 3′, 2-nt overhangs of dsRNA targets. By simply 
designing short guide sequences of RNA complementary to 
an intended target, an argonaute binding site is generated. 
This strategy was successful when utilized in conjunction with 
pumilio domains, but a completely argonaute-based detection 
system remained elusive.
Therefore, in order to provide a sensitive and programma-
ble solution for ssDNA and ssRNA-templated assembly, a sec-
ond strategy was employed that coupled the conditional signal 
generation of reassembled split-luciferase to DNA binding by 
attached high affinity ZF proteins. The fusion constructs are lo-
calized to a single-stranded nucleic acid target through attach-
ment of designed ZF hairpin binding sites to complementary 
guide sequences. The general nature of this technique was es-
tablished through the specific detection of VEGF, hDM2, and 
HER2 mRNA. Notably, this approach allows for distinguish-
ing single base substitutions and detecting the intended target 
with high specificity, while achieving sensitivities as low as 1 
fmol of template. We furthermore anticipate a potential for mul-
tiplexing, given the appropriate design of orthogonal assem-
blies utilizing distinct fragmented proteins, such as different lu-
ciferases.27 We also note a potential caveat for the application 
of this methodology in a cellular context, as this will certainly 
hinge on the ability to successfully deliver the necessary nucleic 
acid polymers, though many recent advances have been made 
in this area.28 An additional consideration must be made re-
garding potential activation of RNase H in response to forma-
tion of the DNA:RNA hybrid produced upon guide binding to 
the target, which may be potentially avoided by utilizing alter-
nate DNA or RNA targeted nucleic acid analogues.2d, 29
More generally, the utility of nucleic acid-templated reac-
tions lies in a strategy borrowed from nature that allows for 
controlling the effective concentration of potential reactants. 
Reactions catalyzed by these techniques range from the clas-
sic phosphodiester bond formation to a variety of new and en-
abling reactions.6, 30 Furthermore, the ability to elicit a condi-
tional output in the presence of a nucleic acid target associated 
with a disease state has far-reaching implications for treat-
ing and curing diverse diseases as recently outlined by Var-
shavsky.10 Although there have been many elegant strategies 
that have promise for eliciting a sequence-specific nucleic acid-
triggered response in a cellular context, our strategy provides 
an alternate protein-based platform that has the potential to 
conditionally activate appropriately fragmented proteins. ds-
DNA-templating of zinc finger domains has been utilized to 
reconstitute nucleases, methylases, and integrases, which sub-
sequently modify the genome, as well as localize transcrip-
tion factors for control of gene expression.9, 31 The methodol-
ogy described herein provides a complementary approach 
predicated on conditional enzyme activation in the presence 
of unmodified single-stranded RNA, ultimately providing a 
mechanism for RNA-templated reassembly of a desired split-
protein that results in targeted modulation of cell fate. For ex-
ample, RNA sequence dependent assembly of enzymes such 
as β-lactamase, caspase, or RNase has the potential to directly 
or indirectly affect cell viability.32
Experimental Methods
Materials. All DNA and RNA oligonucleotides were from 
Integrated DNA Technologies (IDT) and are listed in the main 
text or Supporting Information Table S1. RNasin Plus RNase 
Inhibitor, T7 RiboMAX Large Scale RNA Production kit, Rab-
bit Reticulocyte Lysate (Promega and Alator), and Steady-Glo 
Luciferase Assay System were acquired from Promega. Nucle-
ase-free H2O (Ambion and Promega) was used in all prepara-
tions involving RNA.
RNA-Templated Assembly Using Pumilio and Argo-
naute Domains. The CLuciferase−Pum1 and Pum2−NLucif-
erase constructs have been previously described.13b The RNA 
binding PAZ domain (residues 227−371) of H. sapiens argo-
naute 2 (Ago) was cloned into existing plasmids containing 
split-luciferase (Supporting Information Methods). Genes en-
coding CLuciferase−Ago and Ago−NLuciferase were PCR am-
plified, and the corresponding products served as templates 
for in vitro transcription using a T7 Ribomax RNA production 
kit according to the manufacturer’s suggestions. Generally, 3 
μg of amplified DNA template was incubated at 37 °C for 3 h 
in the presence of 1× T7 transcription buffer, 7.5 mM rNTPs, 
and T7 enzyme mix. To generate argonaute binding sites on 
the RNA targets, RNA guides, containing regions of comple-
mentarity to the pumilio target followed by two 3′-rU’s to fa-
cilitate Ago binding, were annealed to the pumilio target us-
ing the following procedure: heating of target and guide in 
Buffer A (20 mM Tris-acetate, pH 7.9, 50 mM potassium ac-
etate, 10 mM magnesium acetate, and 1 mM DTT) supple-
mented with 0.8 U/μL RNasin to 90 °C for 1 min, followed by 
cooling to 37 °C over 1 h. The mRNAs encoding the split-pro-
teins were translated in the Rabbit Reticulocyte Lysate, con-
sisting of 25 μL reactions prepared in duplicate according to 
the manufacturer’s instructions. A typical reaction was per-
formed at 30 °C for 1.5 h and consisted of the following com-
27. (a) Villalobos, V., Naik, S., and Piwnica-Worms, D. Annu. Rev. Biomed. 
Eng. 2007, 9, 321–349; (b) Hida, N., Awais, M., Takeuchi, M., Ueno, 
N., Tashiro, M., Takagi, C., Singh, T., Hayashi, M., Ohmiya, Y., and 
Ozawa, T. PLos One 2009, 4
28. (a) Sun, Q., Cai, S., and Peterson, B. R. J. Am. Chem. Soc. 2008, 130, 
10064–10065; (b) Dafik, L., Kalsani, V., Leung, A. K. L., and Kumar, K. 
J. Am. Chem. Soc. 2009, 131, 12091–12093
29. (a) Cerritelli, S. M. and Crouch, R. J. FEBS J. 2009, 276, 1494–1505; 
(b) Bennett, C. F. and Swayze, E. E. Annu. Rev. Pharmacol. Toxicol. 
2010, 50, 259–293
30. (a) Gartner, Z. J. and Liu, D. R. J. Am. Chem. Soc. 2001, 123, 6961–
6963; (b) Wrenn, S. J. and Harbury, P. B. Annu. Rev. Biochem. 2007, 
76, 331–349
31. (a) Ansari, A. Z. and Mapp, A. K. Curr. Opin. Chem. Biol. 2002, 6, 765–
772; (b) Alwin, S., Gere, M. B., Guhl, E., Effertz, K., Barbas, C. F., 
Sega, D. J., Weitzman, M. D., and Cathomen, T. Mol. Ther. 2005, 12, 
610–617; (c) Gordley, R. M., Gersbach, C. A., and Barbas, C. F., III. 
Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 5053–5058
32. (a) Sancho, J. and Fersht, A. R. J. Mol. Biol. 1992, 224, 741–747; (b) Chelur, 
D. S. and Chalfie, M. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 2283–2288
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ponents: 66% lysate, 20 μM each amino acid, 70 mM KCl, 1 
mM DTT, 0.8 U/μL RNasin, and 0.1−2 pmol each mRNA tran-
script (Supporting Information Table S2). In the case of CLu-
ciferase−Pum1 and Pum2−NLuciferase, the ssRNA target was 
added prior to initiation of the translation reaction. In all other 
cases, the target with annealed guide(s) was added after trans-
lation, and binding was allowed to occur for 1 h at 4 °C. Ac-
tivity was monitored as a luminescent signal produced upon 
addition of Steady-Glo Luciferase Assay System, where 20 μL 
of each translation was added to 80 μL of Steady-Glo reagent. 
Luminescence readings were acquired 1 min after mixing us-
ing a Turner TD-20e Luminometer with a 10 s integration 
time. Data is presented as the average of duplicate lumines-
cence readings, and results are representative of at least two 
independent trials.
dsDNA-Templated Assembly Using 6-Finger Zinc Fin-
gers. Generation of the plasmids encoding CLuciferase−E2C 
and Aart−NLuciferase is included in the Supporting Infor-
mation Methods. DNA encoding CLuciferase−E2C and Aart−
NLuciferase was amplified from existing plasmids. Transcrip-
tion was performed using a T7 Ribomax RNA production kit 
according to the manufacturer’s instructions, in which a reac-
tion was incubated at 37 °C for 3 h and typically consisted of 
3 μg of amplified DNA template, 1 × T7 transcription buffer, 
7.5 mM rNTPs, and T7 enzyme mix. To demonstrate DNA-
templated reassembly and assess the effect of Herring Sperm 
DNA (HS-DNA) (Invitrogen), duplicate 25 μL reactions were 
carried out in Rabbit Reticulocyte Lysate according to the 
manufacturer’s protocol using 66% lysate, 20 μM each amino 
acid, 70 mM KCl, 1 mM DTT, 0.8 U/μL RNasin, 10 μM ZnCl2, 
0.4 pmol of CLuciferase−E2C, 0.2 pmol of Aart−NLuciferase 
mRNA, and either 300 pM (920 pg) E2C-1-Aart, 300 pM E2C-1-
Aart plus 92 ng HS-DNA, or 92 ng HS-DNA. To determine the 
limit of DNA detection, duplicate 25 μL reactions were carried 
out in Rabbit Reticulocyte Lysate according to the manufac-
turer’s protocol using 66% lysate, 20 μM each amino acid, 70 
mM KCl, 1 mM DTT, 0.8 U/μL RNasin, 10 μM ZnCl2, 0.1 pmol 
CLuciferase−E2C mRNA, 0.2 pmol Aart−NLuciferase mRNA, 
and 100, 50, 25, 10, 5, or 2 pM E2C-1-Aart dsDNA. To dem-
onstrate binding to designed dsDNA hairpins, translations in-
cluded 66% lysate, 20 μM each amino acid, 70 mM KCl, 1 mM 
DTT, 0.8 U/μL RNasin, 10 μM ZnCl2, 0.4 pmol of CLucifer-
ase−E2C, 0.2 pmol of Aart−NLuciferase mRNA, 300 pM Aart-
1-E2C dsDNA target, and 300, 100, 50, 10, 5, 1, 0.5, or 0.1 nM 
Aart hairpin DNA. In all cases, translations were incubated for 
90 min at 30 °C and assayed by adding 80 μL of Steady-Glo 
Luciferase Assay System to 20 μL of translated lysate. Light 
emission was monitored 1 min after substrate addition using 
a Turner TD-20e luminometer or a Turner Biosystems 20/20n 
luminometer with a 10 s integration time. Data is presented as 
the average of duplicate samples.
Evaluation of CLuciferase-Linker-NLuciferase Re-
assembly. The series of CLuciferase-linker-NLuciferase 
constructs was generated as described in the Supporting 
Information Methods. DNA encoding each CLuciferase-linker-
NLuciferase fusion was PCR amplified, and the corresponding 
products served as templates for in vitro transcription using a 
T7 Ribomax RNA production kit according to the manufac-
turer’s suggestions. Generally, 3 μg of amplified DNA tem-
plate was incubated at 37 °C for 3 h in the presence of 1 × T7 
transcription buffer, 7.5 mM rNTPs, and T7 enzyme mix. The 
mRNAs encoding the proteins fusions were translated indi-
vidually in the Rabbit Reticulocyte Lysate, consisting of 25 μL 
reactions prepared in duplicate according to the manufactur-
er’s instructions. A typical reaction was performed at 30 °C for 
1.5 h and consisted of the following components: 66% lysate, 
20 μM each amino acid, 70 mM KCl, 0.8 U/μL RNasin, and 
2 pmol CLuciferase-linker-NLuciferase mRNA. Activity was 
monitored as a luminescent signal produced upon addition 
of Steady-Glo Luciferase Assay System, where 20 μL of each 
translation was added to 80 μL of Steady-Glo reagent. Lumi-
nescence readings were acquired 1 min after mixing using a 
Turner Biosystems 20/20n luminometer with a 10 s integration 
time. Data is presented as the average of duplicate lumines-
cence readings, and results are representative of at least two 
independent trials.
RNA Target Site Selection. To identify favorable target 
sites for guide design in an RNA target, we employed the use 
of multiple analysis programs available free-of-charge on the 
Internet. A list of potential sites was first generated by analyz-
ing the entire RNA target sequence with the Promega siRNA 
Target Designer tool ( http://www.promega.com/siRNADe-
signer/ ) and the IDT Antisense Design tool ( http://www.
idtdna.com/scitools/applications/antisense/antisense.aspx 
). From this collection of sites, pairs were identified that had 
small (2−3 nt) separations between them. The melting temper-
ature of each oligonucleotide was determined using IDT Sci-
Tools OligoAnalyzer 3.1 ( http://www.idtdna.com/analyzer/
applications/oligoanalyzer ). Additionally, potential oligonu-
cleotide sequences were analyzed to ensure that they would 
not anneal to alternate sites in the target using pDRAW32 
DNA analysis software ( http://www.acaclone.com ). The 
entire RNA target was also analyzed by mFold, but long un-
structured regions were generally not observed.33 The infor-
mation from each analysis source was complied, and potential 
sets (generally 5−6) were compared. Ultimately, the set with 
the highest melting temperature was selected, provided that 
all other criteria were satisfied.
Generation of Ternary RNA Targets. Single-stranded 
RNA and DNA oligonucleotide targets were obtained from 
Integrated DNA Technologies (IDT). DNA encoding VEGF, 
hDM2, and HER2 was amplified from existing plasmids (Sup-
porting Information Methods). Transcription was performed 
according to the manufacturer’s instructions. Generally, 3 μg 
of amplified DNA template was incubated at 37 °C for 3 h in 
the presence of 1 × T7 transcription buffer, 7.5 mM rNTPs, and 
T7 enzyme mix. In all cases, 10 μM ssRNA target was heat de-
natured in Buffer B (10 mM Tris-HCl, pH 7.9, 150 mM NaCl, 
10 mM MgCl2, 1 mM DTT) supplemented with 0.8 U/μL RNa-
sin at 90 °C for 7 min, followed by cooling at a rate of 6 °C/
min to 37 °C for 25 min. Heat denaturation was followed di-
rectly by dilution of the target (1 μM) or blank into equimo-
lar concentrations of the corresponding set of preformed hair-
pins in Buffer B supplemented with 0.8 U/μL RNasin, thus, 
generating a ternary nucleic acid complex. This mixture was 
then held at 37 °C for 30 min. DNA hairpins were preformed 
in Buffer B by an annealing procedure consisting of heating to 
95 °C for 7 min, cooling at a rate of 6 °C/min to 56 °C for 5 
min, followed by cooling at a rate of 6 °C/min to 25 °C for 10 
min. These mixtures were then held at 37 °C for 30 min and 
stored at 4 °C.
RNA-Templated Assembly of Split-Luciferase. CLucifer-
ase−E2C and Aart−NLuciferase mRNA transcripts were gen-
erated as described above. Translations were performed at 30 
°C for 1.5 h in the Rabbit Reticulocyte Lysate according to the 
manufacturer’s instructions. A typical reaction consisted of the 
 
 
 
 
33. (a) Mathews, D. H., Sabina, J., Zuker, M., and Turner, D. H. J. Mol. 
Biol. 1999, 288, 911–940; (b) Zuker, M. Nucleic Acids Res. 2003, 31, 
3406–3415
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 following components: 66% lysate, 20 μM each amino acid, 70 
mM KCl, 1 mM DTT, 0.8 U/μL RNasin, 10 μM ZnCl2, 0.2 pmol 
CLuciferase−E2C mRNA, and 0.2 pmol Aart−NLuciferase 
mRNA. For the detection of ssRNA and ssDNA, oligonucle-
otides or VEGF, hDM2, and HER2 RNA annealed nucleic acid 
ternary complexes (1 nM) or a blank, which contained HP-
guides only, were added after completion of the translation 
reaction. For detection of VEGF in the presence of yeast RNA 
(Ribonucleic acid mixture from baker’s yeast (S. cerevisiae) con-
taining mRNA, tRNA, and rRNA, Sigma R6750), translations 
were performed followed by addition of 500 pM (5.0 ng) an-
nealed VEGF RNA, 500 pM annealed VEGF + 2000-fold mass 
excess (10 μg) yeast RNA, yeast RNA + HP-guides, or HP-
guides only. To determine a VEGF ssRNA limit of detection, 
dilutions of the annealed target or HP-guides only (500, 250, 
125, 62.5, or 10 pM) were used. In most cases, luminescence 
readings were taken following 30 min of incubation with the 
ternary complex at 4 °C. However, to determine a time-depen-
dence of biosensor binding to the ternary VEGF target, incu-
bation times were 5, 10, 20, 30, 45, or 60 min. In all cases, ac-
tivity was monitored as a luminescent signal produced upon 
addition of Steady-Glo Luciferase Assay System, where 20 μL 
of each translation was added to 80 μL of Steady-Glo reagent. 
Luminescence readings were acquired 1 min after mixing us-
ing a Turner Biosystems 20/20n luminometer with a 10 s inte-
gration time. Data is presented as the average of duplicate lu-
minescence readings, and results are representative of at least 
two independent trials.
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Supplementary Methods  
Materials. Restriction enzymes, dNTPs, antarctic phosphatase, and T4 DNA ligase were purchased 
from New England Biolabs (NEB). Pfu Ultra polymerase was obtained from Stratagene. All DNA and 
RNA oligonucleotides were purchased from Integrated DNA Technologies (IDT). RNasin, Steady-
Glo® Luciferase Assay System, and Rabbit Reticulocyte Lysate (Promega or Alator) were obtained 
from Promega. 
Cloning. The RNA binding PAZ domain of Homo sapiens argonaute-2 (Ago) was PCR amplified 
from pIRESneo-FLAG/HA Ago2 corrected (Addgene plasmid 10822),
1
 which encodes residues 1-856 
of hsAgo2. Only the RNA binding domain (residues 227-371) was amplified, since adjacent domains 
have endonuclease activity. This domain of Ago2 is assumed to adopt a stable structure based on the 
crystal structure of the corresponding domain of Ago1, which is 96% similar.
2
 An additional Ago 
construct comprising residues 207-391 was also PCR amplified to investigate if a larger domain would 
be better suited for detection purposes. Ago inserts were ligated to existing plasmids containing 
CLuciferase and NLuciferase, generating pETDuet-CLuciferase-Ago (Sequence S1) and pETDuet-Ago-
NLuciferase (Sequence S2). All methods concerning cloning of Pum2-NLuciferase and CLuciferase-
Pum1 have been described.
3
  
To generate the plasmid, pcDNA3.1(+)-CLuciferase-linker-NLuciferase, DNA encoding NLuciferase 
was PCR amplified from an existing plasmid and inserted into an unmodified pcDNA3.1(+) vector 
(Invitrogen). Next CLuciferase-linker(18 AA) was amplified from an existing plasmid and was ligated 
N-terminal to NLuciferase in the pcDNA3.1(+) vector, creating pcDNA3.1(+)-CLuciferase-linker(18 
AA)-NLuciferase (Sequence S3). To generate extended linkers, CLuciferase-linker(18 AA) was PCR 
amplified from the existing construct using a reverse primer that encoded an additional 5 AAs C-
terminal to the existing linker. This insert was then introduced in place of the initial CLuciferase-
linker(18 AA) DNA, to generate a construct in which the linker was 23 AA. This technique was 
subsequently repeated using CLuciferase-linker(23 AA)-NLuciferase as a template to generate the 28 
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AA linker. To generate shorter linkers, complementary oligonucleotides encoding the linker flanked by 
AgeI and EcoRV restriction sites were annealed and directly ligated to the digested plasmid to replace 
the 18 AA linker. DNA encoding the zinc finger Aart (residues 17-190) was generated by PCR 
amplification from an existing plasmid and ligated into a vector containing NLuciferase, generating 
pETDuet-Aart-NLuciferase (Sequence S4).
4
 DNA encoding the zinc finger E2C (residues 7-180) was 
generated by PCR amplification from an existing plasmid and ligated into a vector containing 
CLuciferase, generating pETDuet-CLuciferase-E2C (Sequence S5).
5
 All sequences were confirmed 
with dideoxynucleotide sequencing at the University of Arizona Sequencing Facility.  
In Vitro Transcription. Genes encoding CLuciferase-Ago, Ago-NLuciferase, CLuciferase-E2C, 
Aart-NLuciferase, and CLuciferase-linker-NLuciferase constructs were PCR amplified using in vitro 
transcription primers containing a T7 RNA Polymerase promoter and a KOZAK sequence in the 
forward primer and a 3' hairpin loop in the reverse primer. These primers were designed so that the 
complementary regions had melting temperatures greater than or equal to 70 °C. A typical PCR 
amplification included an initial heat denaturation of 95 °C for 5 min, followed by 35 cycles of heating 
to 95 °C, cooling at a rate of 6 °C/min to an annealing temperature of 50 °C. Elongation at 72 °C for 3 
minutes completed the cycle. The PCR products were then used as templates for in vitro transcription, 
followed by protein generation in reticulocyte lysate, as described in the main text. Specific mRNA and 
target conditions used in each of the experiments (CLuciferase-Pum1/Pum2-NLuciferase, CLuciferase-
Ago/Pum2-NLuciferase, CLuciferase-Pum1/Ago-NLuciferase, and CLuciferase-Ago/Ago-NLuciferase) 
are provided in Table S2. 
Optimization of the Argonaute Detection Domain. Considering that the Ago domain was only 
successful as a detection domain when utilized in conjunction with a pumilio domain, we investigated 
multiple conditions to improve detection. For comparison to the 5' guide, we generated 5' guide-2, 
which is complementary to 16-nt at the 5' end of the RNA target (Table S1). This guide was annealed to 
the RNA target as described in the main text. In vitro translations were carried out as described, using 2 
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pmol each of CLuciferase-Ago and Pum2-NLuciferase or Ago-NLuciferase. The annealed targets were 
added at 10 nM after translation, followed by luminescence readings as described. The 5' guide and 5' 
guide-2 provided very similar luminescence readings for both sets of sensors (Figure S1, A and B).  
We additionally investigated the use of a larger Ago domain for detection purposes. Specifically, we 
compared Ago domains consisting of residues 227-371 and residues 207-391. In vitro translations were 
carried out as described, using 0.1 pmol each of CLuciferase-Ago and Pum2-NLuciferase or 2 pmol 
each of CLuciferase-Ago and Ago-NLuciferase. In the case of CLuciferase-Ago and Pum2-
NLuciferase, the annealed target (RNA + 5' guide) was added at 10 nM after translation. In the case of 
CLuciferase-Ago and Ago-NLuciferase, the annealed target (RNA + 5' guide + 3' guide) was added at 
10 nM during the translation. Luminescence readings were acquired as described. The two different Ago 
constructs provided very similar luminescence readings for both sets of sensors (Figure S1, C and D). 
Generation of VEGF, HER2, and hDM2 Target mRNA. VEGF dsDNA was PCR amplified from 
an existing plasmid, pQE30-VEGF, which contains nucleotides 109-403 of VEGF cDNA, isoform 165. 
This 295 nucleotide region was amplified using the primers containing a T7 RNA polymerase promoter 
indicated in Table S1. HER2 dsDNA (nucleotides 785-985, based on Genbank NM_004448) was PCR 
amplified from an existing plasmid, pSGHV0-HER2,
6
 which contains a portion of the HER2 
extracellular domain, using primers indicated in Table S1. Due to the presence of contaminating PCR 
products, a gel extraction was performed using a QIAquick PCR purification kit (QIAGEN), resulting in 
isolation of a pure product, as visualized by agarose gel electrophoresis. hDM2 dsDNA nucleotides 306-
854 (based on Genbank NM_002392) was amplified from an existing plasmid. In vitro transcription for 
each of these PCR products was carried out as described in the main text.  
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Sequence S1. DNA encoding CLuciferase-Ago. CLuciferase is in red, the 18 amino acid linker is 
shown in black, and Ago (residues 227-371) is in green. 
atgtccggttatgtaaacaatccggaagcgaccaacgccttgattgacaaggatggatggctacattctggagac 
 M  S  G  Y  V  N  N  P  E  A  T  N  A  L  I  D  K  D  G  W  L  H  S  G  D   
atagcttactgggacgaagacgaacacttcttcatagttgaccgcttgaagtctttaattaaatacaaaggatat 
 I  A  Y  W  D  E  D  E  H  F  F  I  V  D  R  L  K  S  L  I  K  Y  K  G  Y   
caggtggcccccgctgaattggaatcgatattgttacaacaccccaacatcttcgacgcgggcgtggcaggtctt 
 Q  V  A  P  A  E  L  E  S  I  L  L  Q  H  P  N  I  F  D  A  G  V  A  G  L   
cccgacgatgacgccggtgaacttcccgccgccgttgttgttttggagcacggaaagacgatgacggaaaaagag 
 P  D  D  D  A  G  E  L  P  A  A  V  V  V  L  E  H  G  K  T  M  T  E  K  E   
atcgtggattacgtcgccagtcaagtaacaaccgcgaaaaagttgcgcggaggagttgtgtttgtggacgaagta 
 I  V  D  Y  V  A  S  Q  V  T  T  A  K  K  L  R  G  G  V  V  F  V  D  E  V  
ccgaaaggtcttaccggaaaactcgacgcaagaaaaatcagagagatcctcataaaggccaagaagggcggaaag 
 P  K  G  L  T  G  K  L  D  A  R  K  I  R  E  I  L  I  K  A  K  K  G  G  K   
tccaaattgggcctgcagggcggttcaggcggtgggggttctggcgggggtgggagccccggggcacagccagta 
 S  K  L  G  L  Q  G  G  S  G  G  G  G  S  G  G  G  G  S  P  G  A  Q  P  V   
atcgagtttgtttgtgaagttttggattttaaaagtattgaagaacaacaaaaacctctgacagattcccaaagg 
 I  E  F  V  C  E  V  L  D  F  K  S  I  E  E  Q  Q  K  P  L  T  D  S  Q  R   
gtaaagtttaccaaagaaattaaaggtctaaaggtggagataacgcactgtgggcagatgaagaggaagtaccgt 
 V  K  F  T  K  E  I  K  G  L  K  V  E  I  T  H  C  G  Q  M  K  R  K  Y  R  
gtctgcaatgtgacccggcggcccgccagtcaccaaacattcccgctgcagcaggagagcgggcagacggtggag 
 V  C  N  V  T  R  R  P  A  S  H  Q  T  F  P  L  Q  Q  E  S  G  Q  T  V  E  
tgcacggtggcccagtatttcaaggacaggcacaagttggttctgcgctacccccacctcccatgtttacaagtc 
 C  T  V  A  Q  Y  F  K  D  R  H  K  L  V  L  R  Y  P  H  L  P  C  L  Q  V  
ggacaggagcagaaacacacctaccttcccctggaggtctgtaacattgtggcaggacaaagatgtattaaaaaa 
 G  Q  E  Q  K  H  T  Y  L  P  L  E  V  C  N  I  V  A  G  Q  R  C  I  K  K  
ttaacggacaatcagacctcaaccatgatcagagcgactgctaggtcg 
 L  T  D  N  Q  T  S  T  M  I  R  A  T  A  R  S  
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Sequence S2. DNA encoding Ago-NLuciferase. Ago (residues 227-371) is in green, the 17 amino acid 
linker is shown in black, and NLuciferase is in red. 
gcacagccagtaatcgagtttgtttgtgaagttttggattttaaaagtattgaagaacaacaaaaacctctgaca 
 A  Q  P  V  I  E  F  V  C  E  V  L  D  F  K  S  I  E  E  Q  Q  K  P  L  T   
gattcccaaagggtaaagtttaccaaagaaattaaaggtctaaaggtggagataacgcactgtgggcagatgaag 
 D  S  Q  R  V  K  F  T  K  E  I  K  G  L  K  V  E  I  T  H  C  G  Q  M  K   
aggaagtaccgtgtctgcaatgtgacccggcggcccgccagtcaccaaacattcccgctgcagcaggagagcggg 
 R  K  Y  R  V  C  N  V  T  R  R  P  A  S  H  Q  T  F  P  L  Q  Q  E  S  G   
cagacggtggagtgcacggtggcccagtatttcaaggacaggcacaagttggttctgcgctacccccacctccca 
 Q  T  V  E  C  T  V  A  Q  Y  F  K  D  R  H  K  L  V  L  R  Y  P  H  L  P   
tgtttacaagtcggacaggagcagaaacacacctaccttcccctggaggtctgtaacattgtggcaggacaaaga 
 C  L  Q  V  G  Q  E  Q  K  H  T  Y  L  P  L  E  V  C  N  I  V  A  G  Q  R   
tgtattaaaaaattaacggacaatcagacctcaaccatgatcagagcgactgctaggtcgaccggtgggggtggc 
 C  I  K  K  L  T  D  N  Q  T  S  T  M  I  R  A  T  A  R  S  T  G  G  G  G   
ggttcaggcggtgggggttctggtgggggtggtaccgaagacgccaaaaacataaagaaaggcccggcgccattc 
 G  S  G  G  G  G  S  G  G  G  G  T  E  D  A  K  N  I  K  K  G  P  A  P  F   
tatcctctagaggatggaaccgctggagagcaactgcataaggctatgaagagatacgccctggttcctggaaca 
 Y  P  L  E  D  G  T  A  G  E  Q  L  H  K  A  M  K  R  Y  A  L  V  P  G  T   
attgcttttacagatgcacatatcgaggtgaacatcacgtacgcggaatacttcgaaatgtccgttcggttggca 
 I  A  F  T  D  A  H  I  E  V  N  I  T  Y  A  E  Y  F  E  M  S  V  R  L  A   
gaagctatgaaacgatatgggctgaatacaaatcacagaatcgtcgtatgcagtgaaaactctcttcaattcttt 
 E  A  M  K  R  Y  G  L  N  T  N  H  R  I  V  V  C  S  E  N  S  L  Q  F  F   
atgccggtgttgggcgcgttatttatcggagttgcagttgcgcccgcgaacgacatttataatgaacgtgaattg 
 M  P  V  L  G  A  L  F  I  G  V  A  V  A  P  A  N  D  I  Y  N  E  R  E  L   
ctcaacagtatgaacatttcgcagcctaccgtagtgtttgtttccaaaaaggggttgcaaaaaattttgaacgtg 
 L  N  S  M  N  I  S  Q  P  T  V  V  F  V  S  K  K  G  L  Q  K  I  L  N  V   
caaaaaaaattaccaataatccagaaaattattatcatggattctaaaacggattaccagggatttcagtcgatg 
 Q  K  K  L  P  I  I  Q  K  I  I  I  M  D  S  K  T  D  Y  Q  G  F  Q  S  M   
tacacgttcgtcacatctcatctacctcccggttttaatgaatacgattttgtaccagagtcctttgatcgtgac 
 Y  T  F  V  T  S  H  L  P  P  G  F  N  E  Y  D  F  V  P  E  S  F  D  R  D   
aaaacaattgcactgataatgaattcctctggatctactgggttacctaagggtgtggcccttccgcatagaact 
 K  T  I  A  L  I  M  N  S  S  G  S  T  G  L  P  K  G  V  A  L  P  H  R  T   
gcctgcgtcagattctcgcatgccagagatcctatttttggcaatcaaatcattccggatactgcgattttaagt 
 A  C  V  R  F  S  H  A  R  D  P  I  F  G  N  Q  I  I  P  D  T  A  I  L  S   
gttgttccattccatcacggttttggaatgtttactacactcggatatttgatatgtggatttcgagtcgtctta 
 V  V  P  F  H  H  G  F  G  M  F  T  T  L  G  Y  L  I  C  G  F  R  V  V  L   
atgtatagatttgaagaagagctgtttttacgatcccttcaggattacaaaattcaaagtgcgttgctagtacca 
 M  Y  R  F  E  E  E  L  F  L  R  S  L  Q  D  Y  K  I  Q  S  A  L  L  V  P   
accctattttcattcttcgccaaaagcactctgattgacaaatacgatttatctaatttacacgaaattgcttct 
 T  L  F  S  F  F  A  K  S  T  L  I  D  K  Y  D  L  S  N  L  H  E  I  A  S  
gggggcgcacctctttcgaaagaagtcggggaagcggttgcaaaacgcttccatcttccagggatacgacaagga 
 G  G  A  P  L  S  K  E  V  G  E  A  V  A  K  R  F  H  L  P  G  I  R  Q  G  
tatgggctcactgagactacatcagctattctgattacacccgagggggatgataaaccgggcgcggtcggtaaa 
 Y  G  L  T  E  T  T  S  A  I  L  I  T  P  E  G  D  D  K  P  G  A  V  G  K   
gttgttccattttttgaagcgaaggttgtggatctggataccgggaaaacgctgggcgttaatcagagaggcgaa 
 V  V  P  F  F  E  A  K  V  V  D  L  D  T  G  K  T  L  G  V  N  Q  R  G  E   
ttatgtgtcagaggacctatgattatgtccggttatgtaaacaatccggaagcgaccaacgccttgattgacaag 
 L  C  V  R  G  P  M  I  M  S  G  Y  V  N  N  P  E  A  T  N  A  L  I  D  K   
gatgga 
 D  G   
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Sequence S3. CLuciferase-linker(18 AA)-NLuciferase. CLuciferase is shown in red, the 18 amino acid 
linker is shown in black, and NLuciferase is green. The restriction sites flanking the linker, which were 
used to facilitate alterations in the linker length, are boxed. 
atgggtacctccggttatgtaaacaatccggaagcgaccaacgccttgattgacaaggatggatggctacattct    
 M  G  T  S  G  Y  V  N  N  P  E  A  T  N  A  L  I  D  K  D  G  W  L  H  S    
ggagacatagcttactgggacgaagacgaacacttcttcatcgttgaccgcctgaagtctctgattaagtacaaa 
 G  D  I  A  Y  W  D  E  D  E  H  F  F  I  V  D  R  L  K  S  L  I  K  Y  K   
ggctatcaggtggctcccgctgaattggaatccatcttgctccaacaccccaacatcttcgacgcaggtgtcgca 
 G  Y  Q  V  A  P  A  E  L  E  S  I  L  L  Q  H  P  N  I  F  D  A  G  V  A   
ggtcttcccgacgatgacgccggtgaacttcccgccgccgttgttgttttggagcacggaaagacgatgacggaa 
 G  L  P  D  D  D  A  G  E  L  P  A  A  V  V  V  L  E  H  G  K  T  M  T  E   
aaagagatcgtggattacgtcgccagtcaagtaacaaccgcgaaaaagttgcgcggaggagttgtgtttgtggac 
 K  E  I  V  D  Y  V  A  S  Q  V  T  T  A  K  K  L  R  G  G  V  V  F  V  D   
gaagtaccgaaaggtcttaccggaaaactcgacgcaagaaaaatcagagagatcctcataaaggccaagaagggc 
 E  V  P  K  G  L  T  G  K  L  D  A  R  K  I  R  E  I  L  I  K  A  K  K  G   
ggaaagatcgccgtgaccggtggcggtgggggttctggcgggggtgggagcggtggcggttctgatatcgaagac 
 G  K  I  A  V  T  G  G  G  G  G  S  G  G  G  G  S  G  G  G  S  D  I  E  D   
gccaaaaacataaagaaaggcccggcgccattctatccgctggaagatggaaccgctggagagcaactgcataag 
 A  K  N  I  K  K  G  P  A  P  F  Y  P  L  E  D  G  T  A  G  E  Q  L  H  K   
gctatgaagagatacgccctggttcctggaacaattgcttttacagatgcacatatcgaggtggacatcacttac 
 A  M  K  R  Y  A  L  V  P  G  T  I  A  F  T  D  A  H  I  E  V  D  I  T  Y   
gctgagtacttcgaaatgtccgttcggttggcagaagctatgaaacgatatgggctgaatacaaatcacagaatc 
 A  E  Y  F  E  M  S  V  R  L  A  E  A  M  K  R  Y  G  L  N  T  N  H  R  I   
gtcgtatgcagtgaaaactctcttcaattctttatgccggtgttgggcgcgttatttatcggagttgcagttgcg 
 V  V  C  S  E  N  S  L  Q  F  F  M  P  V  L  G  A  L  F  I  G  V  A  V  A   
cccgcgaacgacatttataatgaacgtgaattgctcaacagtatgggcatttcgcagcctaccgtggtgttcgtt 
 P  A  N  D  I  Y  N  E  R  E  L  L  N  S  M  G  I  S  Q  P  T  V  V  F  V   
tccaaaaaggggttgcaaaaaattttgaacgtgcaaaaaaagctcccaatcatccaaaaaattattatcatggat 
 S  K  K  G  L  Q  K  I  L  N  V  Q  K  K  L  P  I  I  Q  K  I  I  I  M  D   
tctaaaacggattaccagggatttcagtcgatgtacacgttcgtcacatctcatctacctcccggttttaatgaa 
 S  K  T  D  Y  Q  G  F  Q  S  M  Y  T  F  V  T  S  H  L  P  P  G  F  N  E   
tacgattttgtgccagagtccttcgatagggacaagacaattgcactgatcatgaactcctctggatctactggt 
 Y  D  F  V  P  E  S  F  D  R  D  K  T  I  A  L  I  M  N  S  S  G  S  T  G   
ctgcctaaaggtgtcgctctgcctcatagaactgcctgcgtgagattctcgcatgccagagatcctatttttggc 
 L  P  K  G  V  A  L  P  H  R  T  A  C  V  R  F  S  H  A  R  D  P  I  F  G   
aatcaaatcattccggatactgcgattttaagtgttgttccattccatcacggttttggaatgtttactacactc 
 N  Q  I  I  P  D  T  A  I  L  S  V  V  P  F  H  H  G  F  G  M  F  T  T  L   
ggatatttgatatgtggatttcgagtcgtcttaatgtatagatttgaagaagagctgtttctgaggagccttcag 
 G  Y  L  I  C  G  F  R  V  V  L  M  Y  R  F  E  E  E  L  F  L  R  S  L  Q   
gattacaagattcaaagtgcgctgctggtgccaaccctattctccttcttcgccaaaagcactctgattgacaaa 
 D  Y  K  I  Q  S  A  L  L  V  P  T  L  F  S  F  F  A  K  S  T  L  I  D  K   
tacgatttatctaatttacacgaaattgcttctggtggcgctcccctctctaaggaagtcggggaagcggttgcc 
 Y  D  L  S  N  L  H  E  I  A  S  G  G  A  P  L  S  K  E  V  G  E  A  V  A   
aagaggttccatctgccaggtatcaggcaaggatatgggctcactgagactacatcagctattctgattacaccc 
 K  R  F  H  L  P  G  I  R  Q  G  Y  G  L  T  E  T  T  S  A  I  L  I  T  P   
gagggggatgataaaccgggcgcggtcggtaaagttgttccattttttgaagcgaaggttgtggatctggatacc 
 E  G  D  D  K  P  G  A  V  G  K  V  V  P  F  F  E  A  K  V  V  D  L  D  T   
gggaaaacgctgggcgttaatcaaagaggcgaactgtgtgtgagaggtcctatgattatgtccggttatgtaaac 
 G  K  T  L  G  V  N  Q  R  G  E  L  C  V  R  G  P  M  I  M  S  G  Y  V  N   
aatccggaagcgaccaacgccttgattgacaaggatgga 
 N  P  E  A  T  N  A  L  I  D  K  D  G  
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Sequence S4. DNA encoding Aart-NLuciferase. Aart is in green, the 17 amino acid linker is in black, 
and NLuciferase is shown in red. 
cccggggagaagccctatgcttgtccggaatgtggtaagtccttcagccgcagcgatcacctggccgaacaccag 
 P  G  E  K  P  Y  A  C  P  E  C  G  K  S  F  S  R  S  D  H  L  A  E  H  Q    
cgtacccacacgggtgaaaaaccgtataaatgcccagagtgcggcaaatcttttagcgataagaaagatctgacc 
 R  T  H  T  G  E  K  P  Y  K  C  P  E  C  G  K  S  F  S  D  K  K  D  L  T    
cggcatcaacgcactcatactggcgagaagccatacaaatgtccagaatgtggcaagtctttcagccagcgcgca 
 R  H  Q  R  T  H  T  G  E  K  P  Y  K  C  P  E  C  G  K  S  F  S  Q  R  A   
aacctgcgcgcccaccaacgtactcacaccggggagaagccttatgcttgtccggaatgtggtaagtccttctct 
 N  L  R  A  H  Q  R  T  H  T  G  E  K  P  Y  A  C  P  E  C  G  K  S  F  S   
cagctggcccacctgcgcgcccaccagcgtacccacacgggtgaaaaaccgtataaatgcccagagtgcggcaaa 
 Q  L  A  H  L  R  A  H  Q  R  T  H  T  G  E  K  P  Y  K  C  P  E  C  G  K   
tcttttagccgcgaggataacctgcacacccatcaacgtactcatactggcgagaagccatacaaatgtccagaa 
 S  F  S  R  E  D  N  L  H  T  H  Q  R  T  H  T  G  E  K  P  Y  K  C  P  E  
tgtggcaagtctttctcccgccgcgatgctctgaacgtgcaccaacgtactcacaccggcaaaaaaactagcacc 
 C  G  K  S  F  S  R  R  D  A  L  N  V  H  Q  R  T  H  T  G  K  K  T  S  T  
ggtgggggtggcggttcaggcggtgggggttctggtgggggtggtaccgaagacgccaaaaacataaagaaaggc 
 G  G  G  G  G  S  G  G  G  G  S  G  G  G  G  T  E  D  A  K  N  I  K  K  G   
ccggcgccattctatcctctagaggatggaaccgctggagagcaactgcataaggctatgaagagatacgccctg 
 P  A  P  F  Y  P  L  E  D  G  T  A  G  E  Q  L  H  K  A  M  K  R  Y  A  L   
gttcctggaacaattgcttttacagatgcacatatcgaggtgaacatcacgtacgcggaatacttcgaaatgtcc 
 V  P  G  T  I  A  F  T  D  A  H  I  E  V  N  I  T  Y  A  E  Y  F  E  M  S   
gttcggttggcagaagctatgaaacgatatgggctgaatacaaatcacagaatcgtcgtatgcagtgaaaactct 
 V  R  L  A  E  A  M  K  R  Y  G  L  N  T  N  H  R  I  V  V  C  S  E  N  S  
cttcaattctttatgccggtgttgggcgcgttatttatcggagttgcagttgcgcccgcgaacgacatttataat 
 L  Q  F  F  M  P  V  L  G  A  L  F  I  G  V  A  V  A  P  A  N  D  I  Y  N   
gaacgtgaattgctcaacagtatgaacatttcgcagcctaccgtagtgtttgtttccaaaaaggggttgcaaaaa 
 E  R  E  L  L  N  S  M  N  I  S  Q  P  T  V  V  F  V  S  K  K  G  L  Q  K  
attttgaacgtgcaaaaaaaattaccaataatccagaaaattattatcatggattctaaaacggattaccaggga 
 I  L  N  V  Q  K  K  L  P  I  I  Q  K  I  I  I  M  D  S  K  T  D  Y  Q  G  
tttcagtcgatgtacacgttcgtcacatctcatctacctcccggttttaatgaatacgattttgtaccagagtcc 
 F  Q  S  M  Y  T  F  V  T  S  H  L  P  P  G  F  N  E  Y  D  F  V  P  E  S  
tttgatcgtgacaaaacaattgcactgataatgaattcctctggatctactgggttacctaagggtgtggccctt 
 F  D  R  D  K  T  I  A  L  I  M  N  S  S  G  S  T  G  L  P  K  G  V  A  L  
ccgcatagaactgcctgcgtcagattctcgcatgccagagatcctatttttggcaatcaaatcattccggatact 
 P  H  R  T  A  C  V  R  F  S  H  A  R  D  P  I  F  G  N  Q  I  I  P  D  T   
gcgattttaagtgttgttccattccatcacggttttggaatgtttactacactcggatatttgatatgtggattt 
 A  I  L  S  V  V  P  F  H  H  G  F  G  M  F  T  T  L  G  Y  L  I  C  G  F   
cgagtcgtcttaatgtatagatttgaagaagagctgtttttacgatcccttcaggattacaaaattcaaagtgcg 
 R  V  V  L  M  Y  R  F  E  E  E  L  F  L  R  S  L  Q  D  Y  K  I  Q  S  A   
ttgctagtaccaaccctattttcattcttcgccaaaagcactctgattgacaaatacgatttatctaatttacac 
 L  L  V  P  T  L  F  S  F  F  A  K  S  T  L  I  D  K  Y  D  L  S  N  L  H   
gaaattgcttctgggggcgcacctctttcgaaagaagtcggggaagcggttgcaaaacgcttccatcttccaggg 
 E  I  A  S  G  G  A  P  L  S  K  E  V  G  E  A  V  A  K  R  F  H  L  P  G   
atacgacaaggatatgggctcactgagactacatcagctattctgattacacccgagggggatgataaaccgggc 
 I  R  Q  G  Y  G  L  T  E  T  T  S  A  I  L  I  T  P  E  G  D  D  K  P  G   
gcggtcggtaaagttgttccattttttgaagcgaaggttgtggatctggataccgggaaaacgctgggcgttaat 
 A  V  G  K  V  V  P  F  F  E  A  K  V  V  D  L  D  T  G  K  T  L  G  V  N   
cagagaggcgaattatgtgtcagaggacctatgattatgtccggttatgtaaacaatccggaagcgaccaacgcc 
 Q  R  G  E  L  C  V  R  G  P  M  I  M  S  G  Y  V  N  N  P  E  A  T  N  A   
ttgattgacaaggatgga 
 L  I  D  K  D  G  
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Sequence S5. DNA encoding CLuciferase-E2C. CLuciferase is in red, the 14 amino acid linker is in 
black, and E2C is shown in green. 
 
atgtccggttatgtaaacaatccggaagcgaccaacgccttgattgacaaggatggatggctacattctggagac 
 M  S  G  Y  V  N  N  P  E  A  T  N  A  L  I  D  K  D  G  W  L  H  S  G  D   
atagcttactgggacgaagacgaacacttcttcatagttgaccgcttgaagtctttaattaaatacaaaggatat 
 I  A  Y  W  D  E  D  E  H  F  F  I  V  D  R  L  K  S  L  I  K  Y  K  G  Y   
caggtggcccccgctgaattggaatcgatattgttacaacaccccaacatcttcgacgcgggcgtggcaggtctt 
 Q  V  A  P  A  E  L  E  S  I  L  L  Q  H  P  N  I  F  D  A  G  V  A  G  L   
cccgacgatgacgccggtgaacttcccgccgccgttgttgttttggagcacggaaagacgatgacggaaaaagag 
 P  D  D  D  A  G  E  L  P  A  A  V  V  V  L  E  H  G  K  T  M  T  E  K  E   
atcgtggattacgtcgccagtcaagtaacaaccgcgaaaaagttgcgcggaggagttgtgtttgtggacgaagta 
 I  V  D  Y  V  A  S  Q  V  T  T  A  K  K  L  R  G  G  V  V  F  V  D  E  V   
ccgaaaggtcttaccggaaaactcgacgcaagaaaaatcagagagatcctcataaaggccaagaagggcggaaag 
 P  K  G  L  T  G  K  L  D  A  R  K  I  R  E  I  L  I  K  A  K  K  G  G  K   
tccaaattgggcctgcagggcggttcaggcggtgggggttctggcgggggtgggagccccggggagaagccctat 
 S  K  L  G  L  Q  G  G  S  G  G  G  G  S  G  G  G  G  S  P  G  E  K  P  Y   
gcttgtccggaatgtggtaagtccttcagtaggaaggattcgcttgtgaggcaccagcgtacccacacgggtgaa 
 A  C  P  E  C  G  K  S  F  S  R  K  D  S  L  V  R  H  Q  R  T  H  T  G  E   
aaaccgtataaatgcccagagtgcggcaaatcttttagtcagtcgggggatcttaggcgtcatcaacgcactcat 
 K  P  Y  K  C  P  E  C  G  K  S  F  S  Q  S  G  D  L  R  R  H  Q  R  T  H   
actggcgagaagccatacaaatgtccagaatgtggcaagtctttcagtgattgtcgtgatcttgcgaggcaccaa 
 T  G  E  K  P  Y  K  C  P  E  C  G  K  S  F  S  D  C  R  D  L  A  R  H  Q   
cgtactcacaccggggagaagccctatgcttgtccggaatgtggtaagtccttctctcagagctctcacctggtg 
 R  T  H  T  G  E  K  P  Y  A  C  P  E  C  G  K  S  F  S  Q  S  S  H  L  V   
cgccaccagcgtacccacacgggtgaaaaaccgtataaatgcccagagtgcggcaaatcttttagtgactgccgc 
 R  H  Q  R  T  H  T  G  E  K  P  Y  K  C  P  E  C  G  K  S  F  S  D  C  R   
gaccttgctcgccatcaacgcactcatactggcgagaagccatacaaatgtccagaatgtggcaagtctttcagc 
 D  L  A  R  H  Q  R  T  H  T  G  E  K  P  Y  K  C  P  E  C  G  K  S  F  S   
cgctctgacaagctggtgcgtcaccaacgtactcacaccggtaaaaaaactagt 
 R  S  D  K  L  V  R  H  Q  R  T  H  T  G  K  K  T  S    
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Supplementary Tables 
 
RNA guides  
5' guide 5'CUAUAUACACCAUGUU 
3' guide 
5' guide-2 
5'GCCGCUAUAUCAAUU 
5'GACUAUAUACACCAUGUU 
  
Aart hairpin 5'GCATGTAGGGAAAAGCCCGGCGTCCTCGCCGGGCTTTTCCCTACATGC 
  
RNA target primers
 
 
VEGF FWD 5'GCAGCTAATACGACTCACTATAGGCATCACGAAGTGGTGAAGTTCATGGATGTCTATCAGC 
VEGF REV 5'CTTTCTTTGGTCTGCATTCACATTTGTTGTGCTGTAGGAAGC 
HER2 FWD 5'GCAGCTAATACGACTCACTATAGGCTGATAGACACCAACCGCTCTCGGGC 
HER2 REV 5'GTGCTTGGGGCCCGTGCAGC 
hDM2 FWD 5'GCAGCTAATACGACTCACTATAGGATGTGCAATACCAACATGTCTGTACCTACTGATGGTG 
hDM2 REV 5'GCGTTTTCTTTGTCGTTCACCAGATAATTCATCTGAATTTTCTTCTGTCTCAC 
  
Hairpin-guides  
VEGF(64-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAG 
VEGF(81-95)-Aart 5'TCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(62-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAGGG 
VEGF(81-97)-Aart 5'TCTCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(60-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAGGGTC 
VEGF(81-99)-Aart 5'GATCTCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(58-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAGGGTCTC 
VEGF(81-101)-Aart 5'TCGATCTCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(56-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAGGGTCTCGA 
VEGF(81-103)-Aart 5'ACTCGATCTCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(54-78)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGAAGATGTCCACCAGGGTCTCGATT 
VEGF(81-105)-Aart 5'GTACTCGATCTCATCAGGGTACTCCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
VEGF(216-243)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAAGCCTTGGTGAGGTTTGATC 
VEGF(237-255)-Aart 5'GCTCATCTCTCCTATGTGCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG  
HER2(100-118)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAACGGCACAGACAGTGCGCGT 
HER2(122-140)-Aart 5'CCCTTGCAGCGGGCACAGCAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
hDM2(43-61)-E2C 5'GAGGGGCCGGAGCCGCAGTGCGTCCTCGCACTGCGGCTCCGGCCCCTCAAAACTGGAATCTGTGAGGTGGT 
hDM2(64-82)-Aart 5'CCAGGGTCTCTTGTTCCGAAAAACTCCGGGCTTTTCCCTACATGCTCCTGCATGTAGGGAAAAGCCCGGAG 
 
Table S1. Oligonucleotides used in this study. For the Aart hairpin, the complementary regions forming the Aart binding site are shown in 
red, and the loop is in green. For the RNA target primers, the T7 RNA Polymerase promoter is shown in blue. For the hairpin-guides, the 
complementary hairpin sequences are shown in red, the loop is in green, and the guide sequence is in blue. The numbers in parentheses 
S11 
 
indicate the intended target binding location relative to the beginning of the transcript, which is designated as position 1. Unless otherwise 
specified, all VEGF experiments use the VEGF(60-78)-E2C and VEGF(81-99)-Aart guides.  
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Table S2. In vitro translation conditions used corresponding to the data presented in Figures 2A-D of 
the main text. 
 
mRNA 1 mRNA 2 Final target concentration 
2 pmol Pum2-NLuciferase 2 pmol CLuciferase-Pum1 10 nM target 
0.1 pmol Pum2-NLuciferase 0.1 pmol CLuciferase-Ago 10 nM 5ʹ guide + 10 nM target 
1 pmol Ago-NLuciferase 1 pmol CLuciferase-Pum1 10 nM 3ʹ guide + 10 nM target 
2 pmol Ago-NLuciferase 2 pmol CLuciferase-Ago 10 nM 5ʹ guide + 10 nM 3ʹ guide + 10 nM target 
 
 
 
 
Table S3. Data for the E2C-1-Aart detection limit corresponding to Figure 3C of the main text. 
 
  sample 1 sample 2 
[E2C-1-Aart] (pM) reading 1 reading 2 reading 1 reading 2 
100 153 159 155.5 152.2 
50 88 86 87.1 93.7 
25 41 44 38.7 41.3 
10 18 19 18.7 18.7 
5 11 12 9.9 10.7 
2 6.1 7.1 5.9 5.2 
0 2.5 2.8 2.1 1.6 
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Table S4. Presence of guide sites in yeast and human genomes. Sites shown in blue were used in a 
custom algorithm (bsite, Segal and Korf, unpublished) to search for sites with up to two mismatches in 
the genomes of Saccharomyces cerevisiae (Build 2.1) and human (Build 37.1). The number of sites is 
shown with numbers of mismatches in parentheses. 
 
Hairpin-guides 
 Sites in Saccharomyces 
cerevisiae 
Sites in Homo 
sapiens 
VEGF(60-78)-E2C 5'GAAGATGTCCACCAGGGTC 0 
 
1 (0) 
2 (1) 
37 (2) 
VEGF(81-99)-Aart 5'GATCTCATCAGGGTACTCC 0 1 (0) 
4 (1) 
70 (2) 
VEGF(216-243)-E2C 5'GCCTTGGTGAGGTTTGATC 0 
 
1 (0) 
2 (1) 
23 (2) 
VEGF(237-255)-Aart 5'GCTCATCTCTCCTATGTGC  0 2 (0) 
1 (1) 
36 (2) 
HER2(100-118)-E2C 5'CGGCACAGACAGTGCGCGT 0 
 
1 (0) 
0 (1) 
2 (2) 
HER2(122-140)-Aart 5'CCCTTGCAGCGGGCACAGC 0 3 (0) 
0 (1) 
41 (2) 
hDM2(43-61)-E2C 5'CTGGAATCTGTGAGGTGGT 0 1 (0) 
4 (1) 
145 (2) 
hDM2(64-82)-Aart 5'CCAGGGTCTCTTGTTCCGA 0 1 (0) 
0 (1) 
47 (2) 
GAL4 (Sc control seq) 5'TGTTTAAACTTAAGGGATC 1 (0) N/D 
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Supplementary Figures 
 
 
 
Figure S1. Optimization of the argonaute detection domain. (A) CLuciferase-Ago (Ago residues 227-
371) and Pum2-NLuciferase were reassembled in the presence of the RNA target hybridized to either 5' 
guide or 5' guide-2, followed by luminescence readings (ALU). (B) CLuciferase-Ago and Ago-
NLuciferase were reassembled in the presence of the RNA target hybridized to 3' guide and either 5' 
guide or 5' guide-2, followed by luminescence readings. (C) Two different Ago constructs, residues 
207-391 or 227-371, were utilized as detection domains. CLuciferase-Ago(207-391) or CLuciferase-
Ago(227-371) and Pum2-NLuciferase were reassembled in the presence of the RNA target hybridized 
to the 5' guide, followed by luminescence readings. (D) CLuciferase-Ago(207-391) and Ago(207-391)-
NLuciferase or CLuciferase-Ago(227-371) and Ago(227-371)-NLuciferase were reassembled in the 
presence of the RNA target hybridized to the 3' guide and 5' guide, followed by luminescence readings. 
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Figure S2. Limitations to RNA-templated split-luciferase reassembly using the Ago domain. (A) Ago 
can function effectively (18-fold signal) as a detection domain when a guide sequence is provided that is 
complementary to the 5' end of an RNA target. (B) When the 3' end of the guide sequence is present at 
an internal site in the target RNA, Ago affinity is reduced as judged by a reduced luminescence signal 
(4.5-fold signal). (C) Utilizing both guide sequences in tandem results in the expectation that a statistical 
distribution of Ago-luciferase halves bound to the RNA target would only permit ~50% split-luciferase 
complementation.  
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Figure S3. CLuciferase-linker-NLuciferase constructs. (A) The amino acid (AA) sequences of the 
linkers between CLuciferase and NLuciferase in the pcDNA-3.1(+)-CLuciferase-linker-NLuciferase 
constructs are presented. (B) Translations of CLuciferase-linker-NLuciferase constructs with 8, 14, 18, 
23, and 28 AA linkers were performed in the presence of 
35
S-methionine, and results were analyzed by 
SDS-PAGE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4. Generality of HP-guide design. HP-guides targeting regions 60-78/81-99 or 216-234/237-
255 in the VEGF RNA template were annealed in the presence of the VEGF target. CLuciferase-E2C 
and Aart-NLuciferase sensors were incubated with the annealed products (1 nM), followed by 
luminescence readings. Results are presented as luminescence readings relative to the maximal signal 
(RLU). 
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Figure S5. VEGF detection in the presence of yeast RNA. CLuciferase-E2C and Aart-NLuciferase were 
reassembled in the presence of 500 pM (5.0 ng) annealed VEGF target, 500 pM annealed VEGF + 10 
g yeast RNA (2000-fold mass excess), 10 g yeast RNA, or No RNA. Luminescence readings (ALU) 
revealed that yeast RNA does not significantly affect VEGF RNA detection. The data presented in 
Figure 6F of the main text is a sub-set of the data presented here. 
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Figure S6. Effect of yeast RNA on VEGF annealing. VEGF was annealed to HP-guides in the presence 
of different mass excesses of yeast RNA. CLuciferase-E2C and Aart-NLuciferase were reassembled in 
the presence of the annealed VEGF target at 1 nM (10 ng) with no yeast RNA or with 10 ng (1x), 20 ng 
(2x), or 200 ng (20x) yeast RNA, followed by luminescence readings. The data indicate a slight 
decrease in annealing at 20x yeast RNA, although higher amounts were not tested due to experimental 
constraints on higher yeast concentrations. 
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